PD5-08 CONTEMPORARY OUTCOMES OF INGUINAL LYMPH NODE DISSECTION FOR PENILE CANCER IN A MULTICENTER INTERNATIONAL COHORT
Jared M. Gopman,Rosa S. Djajadiningrat,Simon Horenblas,Yao Zhu,Chris Protzel,Wade J. Sexton,Julio Pow-Sang,Patrick N. Espiritu,Timothy J. Kim,Philippe E. Spiess
DOI: https://doi.org/10.1016/j.juro.2014.02.411
IF: 7.6
2014-01-01
The Journal of Urology
Abstract:You have accessJournal of UrologyPenis/Testis: Benign & Malignant Disease I1 Apr 2014PD5-08 CONTEMPORARY OUTCOMES OF INGUINAL LYMPH NODE DISSECTION FOR PENILE CANCER IN A MULTICENTER INTERNATIONAL COHORT Jared M. Gopman, Rosa S. Djajadiningrat, SImon Horenblas, Yao Zhu, Chris Protzel, Wade J. Sexton, Julio Pow-Sang, Patrick N. Espiritu, Timothy J. Kim, and Philippe E. Spiess Jared M. GopmanJared M. Gopman More articles by this author , Rosa S. DjajadiningratRosa S. Djajadiningrat More articles by this author , SImon HorenblasSImon Horenblas More articles by this author , Yao ZhuYao Zhu More articles by this author , Chris ProtzelChris Protzel More articles by this author , Wade J. SextonWade J. Sexton More articles by this author , Julio Pow-SangJulio Pow-Sang More articles by this author , Patrick N. EspirituPatrick N. Espiritu More articles by this author , Timothy J. KimTimothy J. Kim More articles by this author , and Philippe E. SpiessPhilippe E. Spiess More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.411AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Squamous cell carcinoma of the penis (SCCP) represents 0.3-0.5% of U.S. male malignancy cases. In SCCP, inguinal lymph nodes metastasis is the strongest predictor of prognosis. Therefore, inguinal lymph node dissection (ILND) is a key surgical operation for both diagnostic and therapeutic purposes. Nevertheless, ILND has been slow to gain acceptance due to associated morbidity. The present study aims to assess the potential complications associated with ILND across international tertiary care referral centers, and explore possible prognostic factors that increase complication risk. METHODS A retrospective chart review was conducted across 4 international cancer referral centers with expertise in the management of penile cancer. 316 patients underwent a therapeutic ILND from H. Lee Moffitt Cancer Center (n=51), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (n=196), Fudan University Shanghai Cancer Center (n=40), and Rostock University (n=29). The primary endpoint of this study was the incidence of complications, their severity (major vs. minor), and their natural history. The Clavien-Dindo scoring system was used to standardize the reporting of these complications across international cancer centers. RESULTS Of the 316 patients that underwent ILND for SCCP, the median age was 64 years, the median number of lymph nodes removed was 18, the median hospital stay length was 8 days, and the median tumor size was 3.0 cm. 178 patients had a post-operative complication (56.2%). Minor complications occurred in 119 cases (37.5%), with 59 major complications (18.6%). Frequent complications included wound infection (n=63, 35.4%), seroma formation (n=48, 28.2%), wound infection requiring IV antibiotics (n=37, 20.8%), skin flap necrosis (n=23, 12.9%), lymphocele formation without intervention (n=19, 10.7%), lymphocele formation with intervention (n=4, 2.2%), and wound dehiscence (n=13, 7.3%). Most complications resolved with wound care (draining, dressing changes, debridement), or antibiotics (oral, topical, IV). However, 21 patients required additional surgery to correct for the complication (6.6%). The total number of lymph nodes removed (p = 0.007), and length of hospital stay (p = 0.009) are independent predictors of experiencing any complication. CONCLUSIONS This study is the largest report of contemporary outcomes and complication rates for ILND in SCCP and shows that the surgery can be performed safely, with acceptable rates of complications when performed at centers of excellence in the management of penile cancer. © 2014FiguresReferencesRelatedDetails Volume 191Issue 4SApril 2014Page: e92 Peer Review Report Advertisement Copyright & Permissions© 2014MetricsAuthor Information Jared M. Gopman More articles by this author Rosa S. Djajadiningrat More articles by this author SImon Horenblas More articles by this author Yao Zhu More articles by this author Chris Protzel More articles by this author Wade J. Sexton More articles by this author Julio Pow-Sang More articles by this author Patrick N. Espiritu More articles by this author Timothy J. Kim More articles by this author Philippe E. Spiess More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...